Integral Health Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Integral Health Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000,000	Closed	-$31.2M	–	110
2025 Q4	$31.2M	Buy	+1,000,000	New	+$24.6M	1.55%	18
2025 Q2	–	Sell	-500,000	Closed	-$7.68M	–	98
2025 Q1	$7.68M	Hold	500,000	–	–	0.82%	34
2024 Q4	$11M	Buy	+500,000	New	+$9.1M	0.94%	38
2023 Q4	–	Sell	-1,000,000	Closed	-$10.2M	–	93
2023 Q3	$10.2M	Hold	1,000,000	–	–	1.41%	27
2023 Q2	$7.53M	Buy	+1,000,000	New	+$8.11M	0.93%	42

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integral Health Asset Management's TEVA Position: Q1 2026 in Review

Integral Health Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 1,000,000 shares — an estimated $31.2M sold.

Integral Health Asset Management first reported a position in TEVA in Q2 2023 and held it in 5 quarters. The position peaked at $31.2M in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Integral Health Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Integral Health Asset Management sold 1,000,000 Teva Pharmaceuticals shares in Q1 2026, an estimated $31.2M.
Integral Health Asset Management first reported a position in Teva Pharmaceuticals in Q2 2023 and held it in 5 quarters.
Integral Health Asset Management's Teva Pharmaceuticals position peaked at $31.2M in Q4 2025.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.